Lifecore Biomedical Inc (LFCR)
7.02
-0.21
(-2.90%)
USD |
NASDAQ |
Dec 23, 15:28
Lifecore Biomedical Cash from Investing (Quarterly): -3.392M for Aug. 31, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AngioDynamics Inc | -2.405M |
| Precision Optics Corp Inc | -0.0281M |
| Sage Therapeutics Inc | 81.05M |
| Outset Medical Inc | 15.88M |
| NovaBay Pharmaceuticals Inc | -0.002M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.643M |
| Cash from Financing (Quarterly) | 1.093M |
| Free Cash Flow | -8.79M |
| Free Cash Flow Per Share (Quarterly) | -0.1308 |
| Free Cash Flow to Equity (Quarterly) | -10.68M |
| Free Cash Flow to Firm (Quarterly) | 1.325M |
| Free Cash Flow Yield | -3.55% |